These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
851 related items for PubMed ID: 6130985
21. Luteinizing hormone-releasing hormone (LHRH) and its analogs for contraception in women: a review. Thau RB. Contraception; 1984 Feb; 29(2):143-62. PubMed ID: 6426857 [Abstract] [Full Text] [Related]
22. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. Filicori M, Flamigni C, Meriggiola MC, Ferrari P, Michelacci L, Campaniello E, Valdiserri A, Cognigni G. J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487 [Abstract] [Full Text] [Related]
23. Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRH. Gudmundsson JA, Nillius SJ, Bergquist C. Contraception; 1984 Aug; 30(2):107-14. PubMed ID: 6238805 [Abstract] [Full Text] [Related]
29. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women. Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS. Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914 [Abstract] [Full Text] [Related]
30. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models. Roth C, Hegemann F, Hildebrandt J, Balzer I, Witt A, Wuttke W, Jarry H. Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254 [Abstract] [Full Text] [Related]
32. Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile. Brogden RN, Buckley MM, Ward A. Drugs; 1990 Mar; 39(3):399-437. PubMed ID: 2109679 [Abstract] [Full Text] [Related]
33. Comparisons of the potential utility of LHRH agonists and antagonists for fertility control. Vickery BH. J Steroid Biochem; 1985 Nov; 23(5B):779-91. PubMed ID: 3001420 [Abstract] [Full Text] [Related]
34. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C. J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511 [Abstract] [Full Text] [Related]
35. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. Behre HM, Nashan D, Hubert W, Nieschlag E. J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833 [Abstract] [Full Text] [Related]
36. Hormonal responses in pubertal males to pulsatile gonadotropin releasing hormone (GnRH) administration. Gordon D, Cohen HN, Beastall GH, Perry B, Thomson JA. J Endocrinol Invest; 1988 Feb; 11(2):77-83. PubMed ID: 3129488 [Abstract] [Full Text] [Related]
39. Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Harrison GS, Wierman ME, Nett TM, Glode LM. Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448 [Abstract] [Full Text] [Related]
40. Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty. Soliman AT, elZalabany MM, Ragab M, Abdel Fattah M, Hassab H, Rogol AD, Ansari BM. J Trop Pediatr; 2000 Apr; 46(2):79-85. PubMed ID: 10822933 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]